Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Persistent Asthma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00046748
What this trial is testing

Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 484
Large-scale testing (Phase 3)Study completedNCT00529529
What this trial is testing

Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 805
Large-scale testing (Phase 3)Study completedNCT02559791
What this trial is testing

Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma

Who this might be right for
Severe Persistent AsthmaEosinophilic Bronchitis
McMaster University 10
Not applicableStudy completedNCT01286532
What this trial is testing

Asthma in Children

Who this might be right for
Asthma
AstraZeneca 283
Not applicableStudy completedNCT01350336
What this trial is testing

Bronchial Thermoplasty in Severe Persistent Asthma

Who this might be right for
Severe Asthma
Boston Scientific Corporation 284
Not applicableStudy completedNCT03563521
What this trial is testing

Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma

Who this might be right for
Asthma PersistentAsthma, AllergicEosinophilic Asthma+1 more
TC Erciyes University 95
Testing effectiveness (Phase 2)Ended earlyNCT02219048
What this trial is testing

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Who this might be right for
Asthma
Pfizer 51
Not applicableStudy completedNCT02659618
What this trial is testing

Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma

Who this might be right for
Severe Persistent Asthma
Rush University Medical Center 20
Large-scale testing (Phase 3)Study completedNCT00599027
What this trial is testing

An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

Who this might be right for
Allergic RhinitisAsthma
Organon and Co 51
Large-scale testing (Phase 3)Study completedNCT01099722
What this trial is testing

Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma

Who this might be right for
Asthma
Mundipharma Research Limited 261
Post-approval studies (Phase 4)Study completedNCT00670930
What this trial is testing

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 36
Not applicableWithdrawnNCT01745809
What this trial is testing

Bronchoscopy Study for Severe Asthma

Who this might be right for
Severe Persistent Asthma
University of Pennsylvania
Large-scale testing (Phase 3)Study completedNCT06657066
What this trial is testing

EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA

Who this might be right for
Asthma Patients
King Edward Medical University 74
Testing effectiveness (Phase 2)Study completedNCT01311661
What this trial is testing

Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 206
Post-approval studies (Phase 4)Study completedNCT01476059
What this trial is testing

Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT

Who this might be right for
Asthma
GlaxoSmithKline 472
Large-scale testing (Phase 3)Study completedNCT01449162
What this trial is testing

Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

Who this might be right for
Asthma
AB Science 420
Testing effectiveness (Phase 2)Study completedNCT00873860
What this trial is testing

Study to Evaluate the Safety and Efficacy of CAT-354

Who this might be right for
Asthma
MedImmune LLC 357
Not applicableWithdrawnNCT00954850
What this trial is testing

A National Program for Severe Asthma: The Canadian Severe Asthma Network

Who this might be right for
Severe Persistent Asthma
University of Alberta
Large-scale testing (Phase 3)Study completedNCT01634152
What this trial is testing

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 401
Not applicableStudy completedNCT00282516
What this trial is testing

Asthma In-Home Monitoring (AIM) Trial

Who this might be right for
Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines
Tripler Army Medical Center 120
Next Page